NewEdge Advisors LLC Has $1.60 Million Stock Holdings in iShares Biotechnology ETF (NASDAQ:IBB)

NewEdge Advisors LLC increased its position in shares of iShares Biotechnology ETF (NASDAQ:IBB) by 20.1% during the second quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 11,633 shares of the financial services provider’s stock after buying an additional 1,944 shares during the quarter. NewEdge Advisors LLC’s holdings in iShares Biotechnology ETF were worth $1,597,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also added to or reduced their stakes in the company. Future Financial Wealth Managment LLC purchased a new position in shares of iShares Biotechnology ETF during the first quarter valued at approximately $27,000. Bbjs Financial Advisors LLC bought a new position in shares of iShares Biotechnology ETF during the 2nd quarter worth approximately $31,000. Pacifica Partners Inc. boosted its stake in shares of iShares Biotechnology ETF by 118.2% in the 1st quarter. Pacifica Partners Inc. now owns 240 shares of the financial services provider’s stock worth $33,000 after buying an additional 130 shares during the last quarter. YHB Investment Advisors Inc. bought a new position in shares of iShares Biotechnology ETF in the first quarter valued at approximately $37,000. Finally, Mather Group LLC. bought a new position in shares of iShares Biotechnology ETF in the first quarter valued at approximately $57,000. Institutional investors own 62.45% of the company’s stock.

iShares Biotechnology ETF Trading Up 0.9 %

Shares of iShares Biotechnology ETF stock opened at $143.90 on Friday. The business’s fifty day simple moving average is $145.48 and its 200 day simple moving average is $139.10. iShares Biotechnology ETF has a 12 month low of $111.83 and a 12 month high of $150.57.

iShares Biotechnology ETF Dividend Announcement

The firm also recently announced a dividend, which was paid on Monday, September 30th. Stockholders of record on Wednesday, September 25th were paid a dividend of $0.2005 per share. The ex-dividend date of this dividend was Wednesday, September 25th.

iShares Biotechnology ETF Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.